THE National Cancer Centre of Singapore (NCCS) is embarking on one of its most ambitious trials to test how a drug works in humans.

It is coordinating a trial for an experimental drug for head and neck cancers involving 700 patients from 22 institutions over 12 countries.

The clinical trial will test how effective this new drug, called nimotuzumab, is, compared with the standard treatment for the disease now.

For more The Straits Times stories, click here.